 | • レポートコード：GIR-2104Z03076 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、化学療法誘発性悪心・嘔吐治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。化学療法誘発性悪心・嘔吐治療薬の種類別市場規模（既存薬剤、アキンゼオ（ネツピタント‐パロノセトロンFDC）、アロキシ（パロノセトロン）、イメンド（アプレピタント）、カイトリルジェネリック（グラニセトロン）、ゾフランジェネリック（オンダンセトロン）、パイプライン医薬品、SUSTOL（グラニセトロ注射徐放性薬剤）、ロラピタント）、用途別市場規模（セロトニン受容体拮抗薬、NK1受容体拮抗薬）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・化学療法誘発性悪心・嘔吐治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co., Inc.、GlaxoSmithKline plc、Tesaro, Inc.、Helsinn Group、F. Hoffmann-La Roche Ltd.、Heron Therapeutics, Inc.、Dr. Reddy's Laboratories Ltd.、Acacia Pharma、Sun Pharmaceutical Industry Ltd.、Otsuka Holdings Co., Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：既存薬剤、アキンゼオ（ネツピタント‐パロノセトロンFDC）、アロキシ（パロノセトロン）、イメンド（アプレピタント）、カイトリルジェネリック（グラニセトロン）、ゾフランジェネリック（オンダンセトロン）、パイプライン医薬品、SUSTOL（グラニセトロ注射徐放性薬剤）、ロラピタント ・用途別分析2016年-2026年：セロトニン受容体拮抗薬、NK1受容体拮抗薬 ・化学療法誘発性悪心・嘔吐治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・化学療法誘発性悪心・嘔吐治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・化学療法誘発性悪心・嘔吐治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・化学療法誘発性悪心・嘔吐治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・化学療法誘発性悪心・嘔吐治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chemotherapy-Induced Nausea and Vomiting Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chemotherapy-Induced Nausea and Vomiting Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Chemotherapy-Induced Nausea and Vomiting Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chemotherapy-Induced Nausea and Vomiting Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Market segment by Application can be divided into
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
The key market players for global Chemotherapy-Induced Nausea and Vomiting Drugs market are listed below:
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy’s Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Market Analysis by Application
1.3.1 Overview: Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size & Forecast
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value (2016-2026))
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume (2016-2026)
1.4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity Analysis
1.5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Total Production Capacity (2016-2026)
1.5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
1.6.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
1.6.3 Chemotherapy-Induced Nausea and Vomiting Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Merck & Co., Inc. Details
2.1.2 Merck & Co., Inc. Major Business
2.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline plc
2.2.1 GlaxoSmithKline plc Details
2.2.2 GlaxoSmithKline plc Major Business
2.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Tesaro, Inc.
2.3.1 Tesaro, Inc. Details
2.3.2 Tesaro, Inc. Major Business
2.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Helsinn Group
2.4.1 Helsinn Group Details
2.4.2 Helsinn Group Major Business
2.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Heron Therapeutics, Inc.
2.6.1 Heron Therapeutics, Inc. Details
2.6.2 Heron Therapeutics, Inc. Major Business
2.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dr. Reddy’s Laboratories Ltd.
2.7.1 Dr. Reddy’s Laboratories Ltd. Details
2.7.2 Dr. Reddy’s Laboratories Ltd. Major Business
2.7.3 Dr. Reddy’s Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.7.4 Dr. Reddy’s Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Acacia Pharma
2.8.1 Acacia Pharma Details
2.8.2 Acacia Pharma Major Business
2.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sun Pharmaceutical Industry Ltd.
2.9.1 Sun Pharmaceutical Industry Ltd. Details
2.9.2 Sun Pharmaceutical Industry Ltd. Major Business
2.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Otsuka Holdings Co., Ltd.
2.10.1 Otsuka Holdings Co., Ltd. Details
2.10.2 Otsuka Holdings Co., Ltd. Major Business
2.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
2.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturer
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chemotherapy-Induced Nausea and Vomiting Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturer Market Share
3.4.2 Top 6 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturer Market Share
3.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chemotherapy-Induced Nausea and Vomiting Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region
4.1.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2016-2026)
4.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026)
4.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026)
4.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026)
4.5 South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026)
4.6 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Type (2016-2026)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2016-2026)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Application (2016-2026)
6.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2016-2026)
6.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2026)
7.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2026)
7.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
7.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2026)
8.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2026)
8.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
8.3.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region
9.3.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2026)
10.2 South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2026)
10.3 South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
10.3.1 South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Country
11.3.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chemotherapy-Induced Nausea and Vomiting Drugs Typical Distributors
12.3 Chemotherapy-Induced Nausea and Vomiting Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co., Inc. Major Business
Table 5. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 6. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline plc Major Business
Table 9. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 10. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Tesaro, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Tesaro, Inc. Major Business
Table 13. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 14. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Helsinn Group Basic Information, Manufacturing Base and Competitors
Table 16. Helsinn Group Major Business
Table 17. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 18. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Ltd. Major Business
Table 21. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 22. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Heron Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Heron Therapeutics, Inc. Major Business
Table 25. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 26. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dr. Reddy's Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Dr. Reddy's Laboratories Ltd. Major Business
Table 29. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 30. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Acacia Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Acacia Pharma Major Business
Table 33. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 34. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sun Pharmaceutical Industry Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Sun Pharmaceutical Industry Ltd. Major Business
Table 37. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 38. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Otsuka Holdings Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Otsuka Holdings Co., Ltd. Major Business
Table 41. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product and Services
Table 42. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Chemotherapy-Induced Nausea and Vomiting Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Chemotherapy-Induced Nausea and Vomiting Drugs Production Site of Key Manufacturer
Table 48. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2016-2021e) & (K Units)
Table 49. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2021-2026) & (K Units)
Table 50. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021e) & (K Units)
Table 53. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (K Units)
Table 66. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (K Units)
Table 70. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (K Units)
Table 74. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (K Units)
Table 88. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (K Units)
Table 90. South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (K Units)
Table 94. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Chemotherapy-Induced Nausea and Vomiting Drugs Typical Distributors
Table 107. Chemotherapy-Induced Nausea and Vomiting Drugs Typical Customers
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Picture
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2020
Figure 3. Existing Drugs
Figure 4. Akynzeo (Netupitant-Palonosetron FDC)
Figure 5. Aloxi (Palonosetron)
Figure 6. Emend (Aprepitant)
Figure 7. Kytril Generic (Granisetron)
Figure 8. Zofran Generic (Ondansetron)
Figure 9. Pipeline Drugs
Figure 10. SUSTOL (Granisetron Injection extended release)
Figure 11. Rolapitant
Figure 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2020
Figure 13. Serotonin Receptor Antagonists
Figure 14. NK1 Receptor Antagonists
Figure 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (2016-2026) & (K Units)
Figure 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (2016-2026) & (K Units)
Figure 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
Figure 40. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
Figure 41. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
Figure 42. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2020
Figure 43. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2020
Figure 44. Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2026)
Figure 48. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2016-2026)
Figure 49. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026) & (USD Million)
Figure 52. South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (2016-2026) & (USD Million)
Figure 54. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2026)
Figure 55. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2016-2026)
Figure 56. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 57. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2026)
Figure 58. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2016-2026)
Figure 59. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 60. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2026)
Figure 61. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2026)
Figure 62. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2026)
Figure 63. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2026)
Figure 64. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2026)
Figure 65. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2026)
Figure 67. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2026)
Figure 72. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2026)
Figure 73. South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2026)
Figure 74. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2026)
Figure 75. South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の化学療法誘発性悪心・嘔吐（CINV）市場規模・現状・予測（2021年-2027年） Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides…- 世界の術後悪心嘔吐（PONV）市場規模・現状・予測（2021年-2027年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…
- 世界の術後悪心嘔吐（PONV）市場規模・現状・予測（2021年-2027年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…
- 世界のジェネリック腫瘍薬市場 2021：企業別、地域別、種類・用途別 The Generic Oncology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の吸入・点鼻薬ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inhalation and Nasal Sprays Generic Drugs Market The global Inhalation and Nasal Sprays Generic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…